Piani di cura

Colangiocarcinoma FGFR2

FUTIBATINIB (LYTGOBI®)

Epatocarcinoma (HCC)

PEMIGATINIB (Pemazyre®)
ATEZOLIZUMAB (Tecentriq®)

REGORAFENIB (Stivarga®)

LENVATINIB (Lenvima®)

CABOZANTINIB (Cabometix®)

Esofago

NIVOLUMAB (Opdivo®)

Mesotelioma

NIVOLUMAB + IPILIMUMAB (Opdivo® + Yervoy®)

Polmone

CEMIPLIMAB NSCLC (Libtayo®)

SOTORASIB NSCLC (Lumykras®)

ATEZOLIZUMAB NSCLC adiuvante (Tecentriq®)

CAPMATINIB (Tabrecta®)

TEPOTINIB (Tepmetko®)

PRALSETINIB (Gavreto®)

DURVALUMAB (Imfinzi®)

CEMIPLIMAB NSCLC 1 linea PDL1 >= 50 (Libtayo®)

SELPERCATINIB (Retsevmo®)

ATEZOLIZUMAB 1 linea PDL1 >= 50 (Tecentriq®)

NIVOLUMAB + IPILIMUMAB (Opdivo® + Yervoy®)

ALECTINIB (Alecensa®)

ATEZOLIZUMAB ES-SCLC (Tecentriq®)

ATEZOLIZUMAB 2 linea NSCLC (Tecentriq®)

BRIGATINIB (Alunbring®)

CERITINIB (Zykadia®)

CRIZOTINIB (Xalkori®)

DABRAFENIB+TRAMETINIB (Tafinlar® + Mekinist®)

DURVALUMAB (Imfinzi®)

NINTEDANIB (Vargatef®)

NIVOLUMAB (Opdivo®)

PEMBROLIZUMAB 1 e 2 linea (Keytruda®)

LORLATINIB (Lorviqua®)

ROZLYTREK (Entrectinib®)

Rene

NIVOLUMAB + CABOZANTINIB (Opdivo® + Cabometyx®)

NIVOLUMAB (Opdivo®)

PEMBROLIZUMAB + AXITINIB(Keytruda® + Inlyta®)

NIVOLUMAB + IPILIMUMAB (Opdivo® + Yervoy®)

Tumore uroteliale

AVELUMAB (Bavencio®)

PEMBROLIZUMAB (Keytruda®)

Prostata

OLAPARIB (Lynparza®)

PADELIPORFINA (Tookad®)

Testa e Collo

NIVOLUMAB (Opdivo®)

PEMBROLIZUMAB (Keytruda®)

Endometrio

PEMBROLIZUMAB (Keytruda®)

DOSTARLIMAB (Jemperli®)

PEMBROLIZUMAB + LENVATINIB (Keytruda® + Lenvima®)

Cervice Uterina

CEMIPLIMAB (Libtayo®)

PEMBROLIZUMAB (Keytruda®)

Ovaio

OLAPARIB HRD (Lynparza®)

OLAPARIB (Lynparza®)

NIRAPARIB I^ LINEA (Zejula®)

NIRAPARIB (Zejula®)

RUCAPARIB (Rubraca®)

Mammella

OLAPARIB stadio iniziale ad alto rischio (Lynparza®)

PEMBROLIZUMAB TNBC (Keytruda®)

PEMBROLIZUMAB TNBC iniziale (Keytruda®)

OLAPARIB localmente avanzato o metastatico (Lynparza®)

ATEZOLIZUMAB (Tecentriq®)

TALAZOPARIB (Talzenna®)

Melanoma Adiuvante

PEMBROLIZUMAB (Keytruda®)

NIVOLUMAB (Opdivo®)

PEMBROLIZUMAB (Keytruda®)

DABRAFENIB + TRAMETINIB (Tafinlar® + Mekinist®)

Melanoma Metastatico

IPILIMUMAB (Yervoy®)

NIVOLUMAB (Opdivo®)

PEMBROLIZUMAB (Keytruda®)

DABRAFENIB + TRAMETINIB (Tafinlar® + Mekinist®)

VEMURAFENIB + COBIMETINIB (Zelboraf® + Cotellic®)

ENCORAFENIB + BINIMETINIB (Braftovi® + Mektovi®)

NIVOLUMAB + IPILIMUMAB (Opdivo® + Yervoy®)

Melanoma Uveale

TEBENTAFUSP (Kimmtrak®)